CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-07 | Bonello William Chief Financial Officer | Sale | −3,209 | $18.29 | $59K | 98,516 |
| 2022-03-02 | Dieter Cynthia J Chief Accounting Officer | Shares withheld for taxes | −137 | 18,637 | ||
| 2022-03-02 | CARDOZA GEORGE President & COO, Lab Ops | Shares withheld for taxes | −839 | 244,157 | ||
| 2022-03-02 | Bonello William Chief Financial Officer | Shares withheld for taxes | −620 | 101,725 | ||
| 2022-03-02 | Brown Douglas Matthew Chief Strategy Officer | Shares withheld for taxes | −867 | 76,379 | ||
| 2022-03-01 | Gilbert Halley E Chief Legal Officer | Grant or award | +42,036 | 147,396 | ||
| 2022-03-01 | Gilbert Halley E Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +102,623 | 102,623 | ||
| 2022-03-01 | Mallon Mark Chief Executive Officer | Grant or award | +142,457 | 368,051 | ||
| 2022-03-01 | Mallon Mark Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +347,777 | 347,777 | ||
| 2022-03-01 | Dieter Cynthia J Chief Accounting Officer | Grant or award | +9,341 | 18,774 | ||
| 2022-03-01 | Dieter Cynthia J Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +22,805 | 22,805 | ||
| 2022-03-01 | CARDOZA GEORGE President & COO, Lab Ops | Shares withheld for taxes | −503 | 244,996 | ||
| 2022-03-01 | Bonello William Chief Financial Officer | Grant or award | +40,869 | 102,742 | ||
| 2022-03-01 | Bonello William Chief Financial Officer | Shares withheld for taxes | −397 | 102,345 | ||
| 2022-03-01 | Bonello William Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +99,772 | 99,772 | ||
| 2022-03-01 | Brown Douglas Matthew Chief Strategy Officer | Grant or award | +35,030 | 77,246 | ||
| 2022-03-01 | Brown Douglas Matthew Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +85,519 | 85,519 | ||
| 2022-03-01 | Wallar Gina M President, Pharma Services | Grant or award | +11,677 | 33,443 | ||
| 2022-03-01 | Wallar Gina M President, Pharma Services | Grant or award · Stock Option (Right to Buy) | +28,506 | 28,506 | ||
| 2022-01-11 | McKenzie Kathryn B Chief Sustainability/Risk Ofcr | Option exercise | +2,100 | $9.07 | $19K | 49,361 |
Page 21 of 23 · 447 trades